Tagged with Regulation

insurance Jim O’Drobinak came to Puerto Rico at the end of 2011, following a career largely based in Florida, to run Medical Card System (MCS), a major insurance provider on the island. He shares his experiences and challenges to ensure a functioning health system in a time of doubt regarding healthcare…

vaccines BioNet’s CEO, Pham Hong Thai, shares his thoughts on BioNet’s new vaccine that will be launched in the coming year, his belief in Thailand as a research and clinical trials center, and the growth plans for BioNet over the coming years. What drove you to co-found the company and how…

innovation The chairman for the National Innovation Agency (NIA), Mr. Somchet Thinapong, shares his personal ambitions to bring innovation to the forefront of Thailand’s agenda, why innovation is vital to ensuring the success of the nation and where he hopes to see Thailand’s innovation strategy in the coming years. What experiences…

consultancy Prevention versus remediation is the name of the game in regulatory and compliance issues for pharmaceutical manufacturers; the cost of non-compliance is much higher than investing proactively in compliance. Elizabeth Plaza, founder and chairwoman of the board of Puerto Rican-based regulatory and compliance consultancy Pharma-Bio Serv, discusses how her company…

IMS IMS Health recently released its World Review 2015. The new general manager of North Latin America shares the company’s assessment on the performance of the Mexican pharmaceutical market for 2014, what trends are shaping the industry as well as the moderate, yet positive outlook for 2015. How would you assess…

association The industry of medical devices is still not very well understood. Pablo Dávila shared with us his overview on the Mexican market, how the Mexican Association of Innovative Medical Device Industries (AMID) is interested on putting the sector on the map. Could you please tell us a bit more about…

government The pharmaceutical and medical devices industries are both classified as emerging sectors by the Ministry of Economy. The undersecretary of industry and commerce discusses the importance of the sectors to the Mexican economy and how the government is interested in transforming Mexico from a prevalently manufacturing-based into a more innovation-driven…

association The CEO of NAPM reveals how the main challenge facing his members is the length of time needed to register a generic product, taking up to four years and acting as a significant block on investment, discusses the benefits that come with being part of the International Generic Pharmaceutical Alliance…

government In public health everything is a priority. The Undersecretary of Prevention and Health Promotion explains how Mexico’s Ministry of Health is handling the country’s changing epidemiological profile without forgetting communicable diseases and other urgencies affecting the Mexican population. You have been reappointed as Undersecretary of Prevention and Health Promotion in…

cofepris The implementation of third authorized parties has been a very proactive effort implemented by Mexico’s regulatory authority Cofepris to expedite the time to issue sanitary registrations. The CEO of Entimem provides an overview about the system currently in place, the challenges faced as well as benefits such a system offers…

market access Many of the multinational companies with a long-standing presence in Latin America used to have factories in Peru – since the 1990s all of these companies have closed their facilities in the country as part of a consolidation process to other larger countries in the region like Mexico, Brazil or…

government Turkey’s Minister of Health discusses the major achievements of his party in the area of healthcare since 2003, and the key priorities for the country’s healthcare system moving forward. During AKP’s (Justice and Development Party) incumbency, what were the main policies in health, and what are your priorities for future…